EMEA-000703-PIP01-09

Key facts

Invented name
Eucreas
Active substance
  • vildagliptin
  • metformin hydrochloride
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/169/2010
PIP number
EMEA-000703-PIP01-09
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Type 2 diabetes mellitus
Route(s) of administration
Oral use
Contact for public enquiries
Novartis Europharm Limited
paediatric.enquiries@novartis.com
Switzerland
Phone: +41 61 324 1111
Fax: +41 61 324 8001
Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating